Wells Fargo’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-8,373
| Closed | -$126K | – | 6163 |
|
|
2016
Q2 | $126K | Sell |
8,373
-1,483
| -15% | -$22.3K | ﹤0.01% | 4521 |
|
|
2016
Q1 | $120K | Buy |
9,856
+850
| +9% | +$10.3K | ﹤0.01% | 4552 |
|
|
2015
Q4 | $143K | Sell |
9,006
-809
| -8% | -$12.8K | ﹤0.01% | 4515 |
|
|
2015
Q3 | $150K | Buy |
9,815
+296
| +3% | +$4.52K | ﹤0.01% | 4471 |
|
|
2015
Q2 | $231K | Buy |
9,519
+7,460
| +362% | +$181K | ﹤0.01% | 4400 |
|
|
2015
Q1 | $48K | Sell |
2,059
-3,130
| -60% | -$73K | ﹤0.01% | 4846 |
|
|
2014
Q4 | $130K | Buy |
5,189
+2,616
| +102% | +$65.5K | ﹤0.01% | 4496 |
|
|
2014
Q3 | $80K | Buy |
2,573
+1,016
| +65% | +$31.6K | ﹤0.01% | 4635 |
|
|
2014
Q2 | $40K | Buy |
+1,557
| New | +$40K | ﹤0.01% | 4929 |
|
|
2013
Q4 | – | Sell |
-1,986
| Closed | -$41K | – | 5882 |
|
|
2013
Q3 | $41K | Buy |
+1,986
| New | +$41K | ﹤0.01% | 4666 |
|